Dunhill Financial’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Dunhill Financial's EDIT Position: Q3 2026 in Review
Dunhill Financial reduced its Editas Medicine (EDIT) stake by 100% in Q3 2026, selling an estimated $11.7K and leaving 3 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #607.
Dunhill Financial first reported a position in EDIT in Q4 2025 and has held it in 4 quarters since. The position peaked at $13K in Q2 2026. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Dunhill Financial held 3 shares of Editas Medicine worth $10.3K as of Q3 2026.
- Dunhill Financial sold 3,997 Editas Medicine shares in Q3 2026, an estimated $11.7K.
- Editas Medicine made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #607 holding.
- Dunhill Financial first reported a position in Editas Medicine in Q4 2025 and has held it in 4 quarters since.
- Dunhill Financial's Editas Medicine position peaked at $13K in Q2 2026.
- 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.